Table 6.
Clinical and demographic characteristics of validation group
| Overall | Neonates | Paediatric | Adult | |
|---|---|---|---|---|
| Number of patients | 20 | 8 | 4 | 8 |
| Male/Female | 14/6 | 6/2 | 1/3 | 7/1 |
| Weight (kg) | 42.4 (44.5) | 3.6 (0.6) | 21.9 (23.0) | 91.4 (20.7) |
| Age at cannulation (years) | 16.9 (20.4) | 5.5 (8.8) days | 6.0 (7.1) | 39.2 (12.1) |
| Cannulation (VV/VA) | 18/2 | 7/1 | 3/1 | 8/0 |
| CVVH | 13 | 4 | 3 | 6 |
| Serum creatinine (µmol l−1) | 111.5 (74.1) | 65.6 (34.4) | 56.9 (17.9) | 157.3 (79.6) |
| Number of samples per patient | 5.4 (3.1) | 4.9 (4.2) | 4.3 (1.5) | 6.5 (2.3) |
Data are expressed as mean (SD).